Published: May, 2018

Bovine respiratory disease (BRD) refers to a commonly occurring respiratory disorder amongst cattle that might result from a single or a many number of factors combined. The disease has been gaining much traction lately as it substantially impacts the world beef industry. As a consequence, the treatment as well as prevention of bovine respiratory disease is essential in a bid to mitigate its impact on animal production and the overall beef industry.

Virbac Group, Vetoquinol, Boehringer Ingelheim GmbH, Bayer AG, Bimeda Animal Health, Zoetis Services LLC, Merck & Co., Inc., Ceva, and Elanco are some of the topnotch companies in this space. Despite the fact that there exist a large number of market players that are operating in the world bovine respiratory disease treatment market, the vendor landscape is regarded as highly consolidated and this has led to a high degree of competition.

In accordance with the research report on the world market for Bovine Respiratory Disease Treatment by Transparency Market Research (TMR), it has been anticipated that strong growth would prevail in the said market. Transparency Market Research figures out that the international market for bovine respiratory disease treatment will expand from US$ 805.9 mn in the year 2015 to US$ 1543.9 mn by 2024, and expected to expand at a CAGR of 7.6% therein.

bovine respiratory disease treatment market

Asia Pacific is Estimated to Continue with a High Growth Raate Over the Period of Forecast

The world market for bovine respiratory disease treatment has been regionally segmented into the geographies of South America, North America, Asia Pacific, Middle East and Africa, and Europe. From a the geographical point of view, North America which held around 37% of the said market in the year 2015, is estimated to dominate the world market and is anticipated to easily retain its dominance over the forecast period as well. However, due to the population of cattle and the rising incidences of bovine respiratory diseases, the region of Asia Pacific is anticipated to emerge as one of the very lucrative regional markets for the methods of bovine respiratory disease treatment.

Increased Population of Cattle to Encourage Growth of the Market

Of all the key factors that is driving the said market, the increasing consumption of beef is estimated to have much impact on the overall development of the market over the period of forecast. As bovine respiratory diseases account for around 65% to 80% of morbidity and 45% to 75% mortality rate amongst livestock animals, the growing population of cattle will also bolster the need for effective treatment modalities for these diseases. This is forecasted to have a significant positive impact on the world market for bovine respiratory disease treatment.

The information shared that ahs been in this review is based on a TMR report titled, “Bovine Respiratory Disease Treatment Market (Treatment Type - Vaccines, Antibiotics, NSAIDs, and Immunomodulators; Disease Type - Upper Respiratory Tract Infections, Pneumonia (Lower Respiratory Tract Infection), and Diphtheria; Distribution Channel - Veterinary Hospitals, Veterinary Clinics, Private Veterinary Pharmacies, and Veterinary Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

For the study the market has been segmented as follows:

Global Bovine Respiratory Disease Treatment Market Segmentation

  • By Treatment Type
    • Vaccines
    • Antibiotics
    • NSAIDs
    • Immunomodulators
    • Others
  • By Disease Type
    • Upper Respiratory Tract Infections
    • Diphtheria
    • Pneumonia (lower respiratory tract infection)
  • By Distribution Channel
    • Veterinary Hospitals
    • Veterinary Clinics
    • Private Veterinary Pharmacies
    • Veterinary Research Institutes
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • Latin America

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com  
Website: https://www.transparencymarketresearch.com 

.